SOPHiA GENETICS SA (SOPH) has 42 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 36 sales totalling $3.3M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | Menu Philippe Chief Medical Officer | −$39,417 | 5,000 | −2% | No | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 14, 2026 | Xu Zhenyu Chief Scientific Officer | −$31,538 | 4,000 | −1% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 11, 2026 | Van Well Daan Chief Legal Officer | −$47,089 | 6,168 | −2% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Camblong Jurgi Executive Chairman | −$65,120 | 8,500 | −0% | Yes | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | HIBBS KATHY L Director | −$50,818 | 6,250 | −6% | Yes | |
|
|
||||||
Showing the 5 most recent of 42 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free